BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
0.32%
US Tech 100
20,220.31
-0.75%
S&P 500
5,999.66
-0.36%
US Dollar vs CAD
1.40278
-0.19%
Bitcoin
96,875.15
5.33%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Repare Therapeutics Inc (RPTX) Share Price

Repare Therapeutics Inc

Repare Therapeutics Inc (RPTX)

NASDAQ
3.255
0.105
( 3.33% )
Updated: 13:46:52
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.255
Bid
3.23
Ask
3.28
Volume
85,219
3.08 Day's Range 3.29
2.71 52 Week Range 8.49
Market Cap
138.372M
Previous Close
3.15
Open
3.14
Last Trade
1
@
3.255
Last Trade Time
13:47:31
Financial Volume
US$ 271,863
VWAP
3.1902
Average Volume (3m)
119,367
Shares Outstanding
42,510,708
Dividend Yield
-
PE Ratio
-1.47
Earnings Per Share (EPS)
-2.21
Revenue
51.13M
Net Profit
-93.8M

About Repare Therapeutics Inc

Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.reparerx.com
Headquarters
Saint-laurent, Quebec, Can
Founded
-
Repare Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPTX. The last closing price for Repare Therapeutics was US$3.15. Over the last year, Repare Therapeutics shares have traded in a share price range of US$ 2.71 to US$ 8.49.

Repare Therapeutics currently has 42,510,708 shares outstanding. The market capitalization of Repare Therapeutics is US$133.91 million. Repare Therapeutics has a price to earnings ratio (PE ratio) of -1.47.

Ask ADVFN Intelligence (AI)

RPTX Latest News

More News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib

Repare Therapeutics Inc. (β€œRepare” or the β€œCompany”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA...

November 12 2024
Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]

November 07 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 07 2024
Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December 2024, with the plan to begin a registrational...

November 07 2024
Business Wire

Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial

Data presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Repare Therapeutics Inc. (β€œRepare” or the β€œCompany”) (Nasdaq: RPTX), a leading clinical-stage precision...

October 23 2024
Business Wire

Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a PolΞΈ ATPase Inhibitor

Repare Therapeutics Inc. (β€œRepare” or the β€œCompany”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s Phase 1...

October 14 2024
Business Wire

Repare Therapeutics Announces Phase 1 Data Highlighting Camonsertib in Combination with Radiotherapy Treatment Presented at the ASTRO Annual Meeting

Repare Therapeutics Inc. (β€œRepare” or the β€œCompany”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported data highlighting the clinical benefits of camonsertib, a...

September 30 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.36512.62975778552.893.29782.77611355872.94930124CS
4-0.345-9.583333333333.64.012.751299673.17968355CS
120.44515.83629893242.814.012.711193673.30362762CS
260.1053.333333333333.154.292.711291293.42125073CS
52-1.815-35.7988165685.078.492.711739474.60960749CS
156-22.465-87.344479004725.7227.42.7122774410.10582787CS
260-28.795-89.843993759832.0546.442.7120408514.96508117CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VCIGVCI Global Ltd
US$ 4.235
(136.59%)
241.59M
WAITop KingWin Ltd
US$ 0.476211
(98.42%)
116.9M
IDAIT Stamp Inc
US$ 0.618301
(69.40%)
279.03M
HWHHWH International Inc
US$ 0.873
(54.51%)
30.04M
MOVEMovano Inc
US$ 5.53
(53.61%)
453.53k
PGHLPrimega Group Holdings Ltd
US$ 2.4408
(-97.73%)
15.85M
OTLKOutlook Therapeutics Inc
US$ 1.7787
(-63.63%)
60.09M
KDLYKindly MD Inc
US$ 1.07
(-43.39%)
3.07M
IMGCIMG Inc
US$ 0.98
(-38.75%)
4.46M
SYMSymbotic Inc
US$ 23.17
(-38.06%)
18.1M
IDAIT Stamp Inc
US$ 0.62
(69.86%)
279.03M
VCIGVCI Global Ltd
US$ 4.2499
(137.42%)
241.61M
NVDANVIDIA Corporation
US$ 134.40
(-1.84%)
168.4M
WAITop KingWin Ltd
US$ 0.476211
(98.42%)
116.9M
MARAMARA Holdings Inc
US$ 26.82
(7.41%)
75.35M

RPTX Discussion

View Posts
Monksdream Monksdream 3 months ago
RPTX under $3
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
RPTX under $5
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
From that awful Cathie Wood
Repare Therapeutics (RPTX)
icon-rise-1
17%
Shares of Repare Therapeutics traded up ~17% on Thursday after the company announced10 its second-quarter financial results. During its Research and Development Day in the fourth quarter, management will present updates on the company’s preclinical pipeline and disclose the target for RP-1664. Repare Therapeutics is a precision oncology company searching for novel therapeutics targets by using its discovery platform, SNIPRX.
πŸ‘οΈ0
Gator44 Gator44 2 years ago
I believe we going to break 15 on today is close.
πŸ‘οΈ0
ElusTrade ElusTrade 2 years ago
I believe we going hit 15 this week if not more....
πŸ‘οΈ0
akamaii akamaii 2 years ago
Not alone bought on the news sold Friday 1290 flipped twice and long now again till 20 May flip along the way 15 next the deal is good stuff and the stock is down roche just put a seal of approval
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: We just busted-through to a "LUCKY THIRTEEN DOLLARS" price!!! NOT quite to the MOON, as they say. But what-the-FLICK, I'll take it!!

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Something is UP!!!! INDEED, a shinny-new GREEN COLOR for our --- well, at least MY shares --- of RPTX!! RPTX just might have some UPDATE NEWS coming next Monday, Peeps!! (HA-HA-HA!!!)

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: GREEN!!!! Green is beautiful!!! "GREEN-STOCKS-MATTER"!!!!!




"And by the way, iHub, I don't give a FLUCK if Morgan Fairchild just turned Sweet-116-Years old!!!!"
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Oooooops!!! You MM's can NOT keep our little GREEN-PRICE-Parrot away forever!!! So cut-that-out, you reprobate MM's!!!!

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: I just LOVE being ALONE over here!! (However, click handy LINK, below, for the "Bee Gees" EPIC ballad with THAT name!!! Maybe the BEST "ballad" ever done!!! Yet I'll wager that NOBODY here as ever even HEARD about this song!!! HA-HA-HA!!!)



πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Well, good morning, FOLKS!!! (Just trying to get a word in here edgewise is difficult, as you can see! We 'gots' so many POSTS here everyday, the iHub Algorithms simply can't handle the action!! )

In any event, GO-GO-GO-RPTX!!! Take us to the MOON today!! Well, at least maybe to the 'International SPACE STATION??? (HA-HA-HA!!!)

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: NOT a bad day here.
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Hey, 'RA-40' Dude, your post is the BEST point of the DAY about this RPTX-Roche-Company partnership!! Indeed, THAT many SHARES traded at the circa $9-$12 price range is impressive. This Company has nice, BIG, upside PRICE potential. Big-Time-ROCHE didn't cement that HUGE deal today because RPTX is some Stinky-Pinky-Wanna-Be-Big-PHARMA, with scores of USELESS "Patents-Pending"; nor weekly (Elementary School) Petri-Dish-&-Test-Tube-Studies; nor Miraculous-Sick-MICE-Cures!

See-ya tomorrow!!!

πŸ‘οΈ0
retireat40 retireat40 2 years ago
No one noticing? Volume was 139 times normal
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: May have a late-day RUN here, Folks!! Whether anyone likes it, or not!!! (HA-HA-HA!!!)


"Heck, ya never know WHAT-THE-FLUCK is gonna happen on these Stock Market GAMBLING CASINOS these days!!!!"
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: They WILL notice this little GEM, Dude --- soon enough!!!

https://www.fool.com/investing/2022/06/02/why-repare-therapeutics-stock-is-skyrocketing-toda/
πŸ‘οΈ0
ElusTrade ElusTrade 2 years ago
It huge news but no one noticing
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Now UP by a glorious 44%, Peeps & Homeboys!!! Don't miss the FUN -- let alone the PROFITS -- via this MONSTER Medical Science play!!! I guess nobody is YET paying any attention to today's NEWS about this little GEM!!! (HA-HA-HA!!!)

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Ain't gonna be CRICKETS in here for very much longer, Folks!!!!

https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Yet another handy LINK (Fidelity) about this rather NICE news today for RPTX. (HA-HA-HA!!!)
https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=RPTX&pageno=&storyid=202206011618RTRSNEWSCOMBINED_FWN2XO0QP_1&provider=RTRSNEWS&product=COMBINED&
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Welcome aboard, Bro!!! This one is the proverbial, "Biggest No-Brainer In The History Of Mankind" routine!!! (Hey, I DO indeed realize that I am iHub's unoffical 'CLASS CLOWN'; but nevertheless, even FOOLS like me can pick-em ONCE in awhile!! HA-HA-HA!!!)


"Heck, I used to think that the ONLY time in my life that I ever got 'LUCKY', was winning a lousy Two-Dollar-Scratcher for TEN BUCKS in a 7/11-Store back in 1982! But with RPTX, I just hit the MOTHERLODE!!!! Bottom line, finally gettin' some RESPECT!!!!"
πŸ‘οΈ0
Laszlo1 Laszlo1 2 years ago
I am in
πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Ya-all MISSED the take-off!! I am already well on my way to the MOON! Never been there, so it may be interesting!

"This is one small STEP for Mankind; but one GIANT LEAP for the bank account balance of iHub's own JUST-KEEP-TRYING Dude!!!" (HA-HA-HA!!!)

πŸ‘οΈ0
Just-Keep-Trying Just-Keep-Trying 2 years ago
RPTX: Anybody gonna join me for a quick trip to the MOON today??? I can fly there all by MYSELF, but it sure gets LONELY way out there; but, I think I can MUSCLE-through-it, nevertheless. (HA-HA-HA!!)

https://www.marketwatch.com/story/roche-repares-licensing-deal-includes-milestone-payments-worth-up-to-12-billion-2022-06-02

https://pulse2.com/repare-therapeutics-rptx-stock-price-why-it-increased-over-20-today/

https://www.postregister.com/businessreport/healthcare/repare-therapeutics-announces-a-worldwide-license-and-collaboration-agreement-with-roche-for-camonsertib-rp-3500/article_a6d38b6f-626d-51f5-a151-9e0e435be816.html

https://www.marketbeat.com/instant-alerts/nasdaq-rptx-a-buy-or-sell-right-now-2022-06/


"Heck, last time I saw a stock like THIS rocketship, it landed on Planet JUPITER by lunchtime on Wall Street!"
πŸ‘οΈ0

Your Recent History

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00